Louisiana's Cardiovascular Institute of the South (CIS) First to Implant New Orsiro Mission Coronary Artery Stent in Ambulatory Surgical Center Setting

January 19, 2022, Houma, Louisiana – Interventional cardiologists Drs. Craig Walker and Erica Fidone are the first in the country to implant the Orsiro® Mission Coronary Artery Drug Eluting Stent (DES) by BIOTRONIK, Inc. in an ambulatory surgery setting. The procedure took place on January 7 at the Cardiovascular Institute of the South (CIS) Ambulatory Surgical Center in Gray, Louisiana to treat coronary artery disease.

Orsiro^® Mission is a new drug-eluting stent system that offers advanced deliverability and an ultrathin strut design considered the thinnest available in the United States. It features the same proprietary design and innovative bio-absorbable coating with controlled drug release as the Orsiro^® stent. Advantages include a re-engineered delivery system and a new deep embedding process to improve deliverability. Ultimately, this new system is designed for easy delivery by skilled cardiologists to open challenging lesions and restore blood flow to the coronary arteries of the heart.

“When patients experience a blockage in the coronary arteries of their heart, the right stent is needed to open the artery,” explained Dr. Walker. “Drug-eluting stents such as the Orsiro® Mission restore blood flow to the heart muscle, and can relieve symptoms of chest pain as well. The design makes it easy to deliver so that we can continue giving our patients the most advanced treatment options.”

To learn more or to schedule an appointment with a CIS cardiologist, visit www.cardio.com.

About Cardiovascular Institute of the South
Founded by Dr. Craig Walker in 1983, Cardiovascular Institute of the South (CIS) is a world-leader in preventing, detecting and treating cardiovascular and peripheral vascular disease. CIS offers a comprehensive heart and vascular program with expert physicians trained in many specialties, including internal medicine, nuclear cardiology, electrophysiology, lipid management, coronary artery disease, peripheral vascular disease, valve disease and interventional cardiovascular procedures. CIS has earned international acclaim as a pioneer of research, development and education, as well as an innovator in the treatment of peripheral vascular disease. With a dedicated team of more than 1,075 team members, CIS provides comprehensive cardiovascular care at 22 locations across Louisiana and Mississippi, with 10 telemedicine programs. CIS remains at the forefront of technology, providing the highest-quality, compassionate care. This mission has guided the institute for more than 38 years of excellence.  For more information about CIS, call 1-800-425-2565 or visit www.cardio.com.